Skip to main content
Clinical Trials/NCT02818855
NCT02818855
Completed
Phase 4

Treatment of Multiple Gingival Recessions With Collagen Matrix Versus Subepithelial Connective Tissue Graft: A Non-inferiority Randomized Clinical Trial

University of Sao Paulo1 site in 1 country15 target enrollmentMarch 2014

Overview

Phase
Phase 4
Intervention
Coronally advanced flap (CAF)
Conditions
Gingival Recession
Sponsor
University of Sao Paulo
Enrollment
15
Locations
1
Primary Endpoint
Percentage of root coverage (RC)
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Gingival recession (GR) is frequently associated with deterioration in dental esthetics and dental hypersensitivity. Outcomes from recent systematic reviews have demonstrated that when the root is covered and the gain in the width of keratinized tissue (KT) is expected, the use of subepithelial connective tissue grafts (SCTGs) associated with coronally advanced flaps (CAF) appears to be more predictable, and may be considered the gold standard procedure. However, the SCTGs may increase patients' morbidity (e.g., pain). This occurs because of the need for a donor surgical area, which may increase the risk of surgical complications like bleeding, as well as increases post-operative discomfort and the period of the surgical procedure. Another biomaterial, a new collagen matrix (CM) has been used as a substitute for the SCTG. The use of CM was associated with a significant reduction in post-operative morbidity, less post-operative pain and discomfort in the patient, and more esthetic satisfaction.

Registry
clinicaltrials.gov
Start Date
March 2014
End Date
April 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Giuseppe Alexandre Romito

Chairperson, Department of Periodontics

University of Sao Paulo

Eligibility Criteria

Inclusion Criteria

  • The patients will be included in the study if they fulfill the following inclusion criteria:
  • a clinical diagnosis of multiple-recession type defects at maxillary canines and premolars with at least one GR ≥ 3mm in depth;
  • areas of Miller's Class I or II GR;
  • teeth without root abrasions or caries.

Exclusion Criteria

  • The exclusion criteria used will be as follows:
  • patients allergic to collagen
  • a history of smoking (within the previous 6 months)
  • pregnancy or lactation
  • a history of destructive periodontal disease or the formation of recurrent abscesses
  • root caries at the site of recession
  • previous surgical root coverage procedures
  • systemic healing disorders (for example, acquired immunodeficiency syndrome \[AIDS\], diabetes mellitus or risk factors evaluated by a medical doctor)
  • periodontal disease, or poor plaque control (full mouth plaque index \> 20%).
  • The exclusion criteria for teeth will be:

Arms & Interventions

Collagen Matrix plus coronally advanced flap (CAF)

A new collagen matrix (Mucograft) associated to coronally advanced flap

Intervention: Coronally advanced flap (CAF)

Collagen Matrix plus coronally advanced flap (CAF)

A new collagen matrix (Mucograft) associated to coronally advanced flap

Intervention: Collagen Matrix

Subepithelial connective tissue graft plus CAF

Subepithelial connective tissue graft associated to coronally advanced flap

Intervention: Coronally advanced flap (CAF)

Subepithelial connective tissue graft plus CAF

Subepithelial connective tissue graft associated to coronally advanced flap

Intervention: Subepithelial connective tissue graft

Outcomes

Primary Outcomes

Percentage of root coverage (RC)

Time Frame: 12-months

The primary clinical outcome will be percentage of root coverage (RC) at 12 months

Secondary Outcomes

  • Reductions in recession depth (RRD)(At the baseline, 3-month, 6-month and 12-months)
  • Complete root coverage of the gingival recessions (CRC)(At the baseline, 3-month, 6-month and 12-months)
  • Recession width (RW) at the cemento-enamel junction(At the baseline, 3-month, 6-month and 12-months)
  • Relative clinical attachment level (RCAL)(At the baseline, 3-month, 6-month and 12-months)
  • Probing depth (PD)(At the baseline, 3-month, 6-month and 12-months)
  • keratinized tissue width (KT)(At the baseline, 3-month, 6-month and 12-months)
  • Gain in thickness of gingival tissue (GT)(At the baseline, 3-month, 6-month and 12-months)

Study Sites (1)

Loading locations...

Similar Trials